Журнал кардиореспираторных исследований 2025. №2
Subject of the article
EFFECTIVENESS OF THE VALODIP COMBINATION IN ARTERIAL HYPERTENSION (21-24)
Authors
Baimuratova Bagitjamal Nazarbekovna, Jiyen Asiya Kasymovna, Taskinova Maya Adilbekovna, Shermatova Ziyoda Yashnarovna,
Institution
South Kazakhstan Medical Academy
Abstract
Hypertension is a disease characterized by an increase in blood pressure as the main and sudden symptom. Arterial hypertension is one of the most common diseases of the cardiovascular system. Arterial hypertension affects about 20-30% of the adult population in the world. The prevalence of the disease reaches 50-65% with age in people over 65 years of age and can lead to the development of heart attacks and strokes. Currently, the study of arterial hypertension is of great importance, since 8-10% of the population suffers from this disease and it is one of the leading causes of death. Hypertension is widespread in medical practice. Their timely detectionrequires the study of a combination of effective and safe antihypertensive drugs that increase the effectiveness of treatment of the disease.
Key words
valodip combination,urinary albumin, antihypertensive drug combinations.
Literature
1.Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis. DOI: 10.1002/clc.24082 2.Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.doi: 10.3389/fphar.2023.1264321. 3. "Valsartan/Amlodipine Combination Therapy in Hypertension Management" – an article in Hypertension from the American Heart Association examines the efficacy and tolerability of this combination in patients with various forms of hypertension. More information can be found here: Hypertension Journal. 4. “Fixed-Dose Combination of Valsartan and Amlodipine for Hypertension Treatment” For more information: ScienceDirect. 5. Philipp T et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007; 29 (4): 563–80 6. Smith TR et al. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J Clin Hypertens (Greenwich) 2007; 9: 355–64. 7. Poldermans D et al. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin Ther 2007; 29: 279–89 8. Allemann Y et al. A randomized, double-blind, multicenter study to evaluate the efficacy of the combination of amlodipine and valsartan in hypertensive patients uncontrolled on previous monotherapy: The EXFAST Study. J Clin Hypertens 2008; 10 (3): 185–94. 9. Braun N et al. Efficacy and safety of the single pill combination of amlodipine 10mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10mg plus olmesartan 20 mg in free combination. Current Medical Research and Opinion, 2009; 25 (2): 421–30. 10. Arterial hypertension. diseases.medelement.com/disease/артериальная-гипертензия-2019/16296